BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui X, Cao Z, Wang S, Adler SP, McVoy MA, Snapper CM. Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities. Vaccines (Basel) 2020;8:E179. [PMID: 32294946 DOI: 10.3390/vaccines8020179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Spencer Clinton JL, Hoornweg TE, Tan J, Peng R, Schaftenaar W, Rutten VPMG, de Haan CAM, Ling PD. EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice. Vaccine 2022:S0264-410X(22)00891-X. [PMID: 35879117 DOI: 10.1016/j.vaccine.2022.07.016] [Reference Citation Analysis]
2 Petrini S, Maple P. Herpesvirus Vaccines. Vaccines (Basel) 2022;10:628. [PMID: 35455377 DOI: 10.3390/vaccines10040628] [Reference Citation Analysis]
3 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Reference Citation Analysis]
4 Li L, Freed DC, Liu Y, Li F, Barrett DF, Xiong W, Ye X, Adler SP, Rupp RE, Wang D, Zhang N, Fu TM, An Z. A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial. NPJ Vaccines 2021;6:79. [PMID: 34078915 DOI: 10.1038/s41541-021-00342-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Cui X, Cao Z, Ishikawa Y, Cui S, Imadome KI, Snapper CM. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge. Vaccines (Basel) 2021;9:285. [PMID: 33808755 DOI: 10.3390/vaccines9030285] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]